Reduction of NOX4-mediated ROS production was protective in various diseases, including cardiac ischemia/reperfusion injuries, diabetes, and Streptococcus pneumonia infection as well as fibrotic progression (39, 40). This evidence concerns the gene NOX4 and pneumococcal infection.